...BRCA2 carriers without prior breast cancer have the option to undergo risk-reducing mastectomy (RRM). The aim of this st...
...BRCA2 mutation. She began neoadjuvant chemotherapy, but the treatment was stopped early due to severe liver inflammation...
Background/Objectives: Genetic polymorphisms in the BRCA2 gene have been implicated in breast cancer susceptibility. Whi...
...BRCA2, FGFR4, CDKN1B, AURKA, GPX4, TP53, and CASP8 and their association with breast cancer risk among Iranian women, ai...
...BRCA2 is primarily associated with breast and ovarian malignancies. Emerging evidence suggests a potential role of BRCA2...
...BRCA2, contribute to an increased lifetime breast cancer risk in this population. For women with a known pathogenic vari...
...BRCA2-RAD51 DNA break localization; it can also bind BRCA1 or form homodimers with DNA-binding activity via its coiled-c...
...BRCA2, PALB2). Twelve of 21 patients (57 %) diagnosed at age ≤ 39 years had a gPV, all in OC-related genes. No differenc...
...BRCA2, and HR-related gene mutation rates were 17.9%, 3.5%, and 23.1%, respectively, with TP53 as the most frequent soma...
...BRCA2 gene. This case suggests a potential association between BRCA2 gene mutations and the development of ND with renal...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
